PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2008
CASE
AUTH/2188/12/08 Ashfield In2Focus ⭐ Case of the Week

AUTH/2188/12/08: General Practitioner v Ashfield In2Focus (Conduct of a representative) – No breach (outwith scope)

PMCPA case AUTH/2188/12/08: complaint about conduct of a representative. The matter was ruled outwith the scope of the ABPI Code (2008). No…

2010
CASE
AUTH/2363/10/10 Merck Sharp & Dohme

AUTH/2363/10/10: General Practitioner v Merck Sharp & Dohme (Andropause website) β€” No breach (outwith scope)

Complaint about an β€œAndropause” website. PMCPA concluded the matter was outwith the scope of the ABPI Code; no breach was found. Undertaking…

2015
CASE
AstraZeneca

AstraZeneca β€˜Fixing Dad’ HCP webpage ruled promotional in contextβ€”missing prescribing information

AstraZeneca’s β€˜Fixing Dad’ diabetes patient-engagement trailer sat within a promotional HCP medicines site and was used by field force. Panel ruled it…

2018
CASE
AUTH/3107/10/18 Daiichi-Sankyo UK

Daiichi-Sankyo website product pages ruled promotional to the public (AUTH/3107/10/18)

PMCPA ruled Daiichi-Sankyo’s UK website β€œProducts” page promoted POMs to the public by listing brand/generic names and indications plus condition/benefit statements, without…

2016
CASE
AUTH/2904/11/16 Lundbeck

AUTH/2904/11/16: Director v Lundbeck (Selincro) – Clinical trial disclosure

PMCPA case AUTH/2904/11/16 (Director v Lundbeck) concerning clinical trial disclosure for Selincro. Outcome: No breach; matter was outwith the scope of the…

2019
CASE
AUTH/3250/10/19 Janssen ⭐ Case of the Week

AUTH/3250/10/19: Lilly/Director v Janssen – Tremfya (guselkumab) and psoriatic arthritis β€˜pipeline’ session ruled promotional (breach of undertaking)

Janssen’s BSR β€œPipelines in PsA” innovation theatre session was ruled not to be legitimate scientific exchange and to promote Tremfya for an…

2019
CASE
Vifor Pharma

Vifor found in breach over ivironheart.co.uk website promoting IV iron (Ferinject/Venofer) without PI, AE statement or certification

PMCPA ruled ivironheart.co.uk was promotional for Vifor’s IV irons (Ferinject/Venofer). Missing prescribing info, AE reporting statement and certification; content misleading vs oral…

2019
CASE
Novartis Pharmaceuticals UK

Novartis breached ABPI Code over Kisqali leaflet: unclear combination partner and outdated survival-data footnote

A Kisqali leaflet used at a breast cancer meeting was ruled misleading for not clearly limiting MONALEESA-7 survival data to the aromatase…

2020
CASE
AUTH/3308/2/20 GlaxoSmithKline

GSK respiratory webinar pages: missing Relvar prescribing information and undertaking breach; COPD β€˜triple therapy’ appeal succeeds (AUTH/3308/2/20)

GSK’s asthma webinar registration page promoted Relvar but omitted prescribing info and PI location statement, and wasn’t reviewed under a prior undertakingβ€”Clause…

2020
CASE
AUTH/3312/2/20 Johnson

AUTH/3312/2/20: Anonymous v Johnson & Johnson (Nicorette) β€” no breach over β€˜out of date’ prescribing information

Complaint alleged Nicorette journal ad used out-of-date prescribing information after SPC updates. Panel found SPC changes were minor and did not require…

2020
CASE
AUTH/3377/9/20 Britannia Pharmaceuticals ⭐ Case of the Week

Britannia Pharmaceuticals: β€œApo-go Pump” branding ruled misleading (AUTH/3377/9/20)

Employee complaint upheld after Britannia used β€œApo-go Pump” name/logo despite Apo-go not being supplied as a pump. Panel found misleading promotion and…

2020
CASE
AUTH/3382/9/20 Chugai

AUTH/3382/9/20: Complainant v Chugai β€” Granocyte showreel YouTube video (No breach)

Complaint alleged a Granocyte YouTube video promoted a POM to the public, lacked prescribing information and wasn’t recertified. Panel found it was…

2019
CASE
Norgine

Norgine breached ABPI Code over Feraccru email claiming major cost and nursing-time savings vs IV iron

PMCPA ruled Norgine’s Feraccru promotional email overstated economic claims from a small abstract and in-house modelling, omitted key limitations, and downplayed IBD…

2020
CASE
AUTH/3437/12/20 Pfizer

Pfizer: Senior employee’s personal LinkedIn post about Covid-19 vaccine ruled promotional and discrediting (AUTH/3437/12/20)

A senior Pfizer UK employee posted and another β€˜liked’ a LinkedIn update linking to a BBC article about the Pfizer/BioNTech Covid-19 vaccine…

2021
CASE
AUTH/3456/1/21 Boehringer Ingelheim

Boehringer Ingelheim & Eli Lilly: Jardiance cardiology webcast and slides (no breach) | AUTH/3456/1/21 & AUTH/3457/1/21

Complaint alleged Jardiance webcast/slides misled on CV benefits, encouraged off-label use, and hosted outdated prescribing info publicly. PMCPA ruled no breach of…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training